Immunotherapy in acute myeloid leukemia: The antibodies, TriKEs, and CARs on the arduous road to cure
{{output}}
Acute myeloid leukemia (AML) is a complex, heterogeneous and aggressive hematopoietic clonal disorder with limited curative options beyond allogeneic stem cell transplantation. The disease presents significant challenges due to high relapse rates resistance to... ...
